Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Understanding the diagnostic value of Faecal Immunochemical Testing (FIT) in patients with symptoms of colorectal cancer.

In collaboration with Oxfordshire CCG and Oxford University Hospitals Trust we are evaluating the utility of faecal occult blood testing (FOBT) in primary care patients with lower abdominal symptoms. We are comparing the older type of FOBT (guaiac) with the newer type (Faecal Immunochemical Testing or FIT) to establish the diagnostic accuracy of FOBT, and the impact of FOBT use on referrals to specialist care. We hope our findings will inform national guidance on FIT.